The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema
Clinical trial NCT06075147 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06075147
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-15
- Primary completion
- 2027-09-30
- Enrollment
- 2500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.